August 1, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner
 

Tokyo, Aug 8, 2013 (JCN) - Dainippon Screen Mfg. has launched the Cell3iMager (3D cell imager), a high-speed 3D cell culture scanner capable of measuring and analyzing multiplication and morphological changes in cancer cells grown on 3D cell culture plates without using a reagent. Screen plans to use the release of the system in July as an opportunity to establish itself in the life sciences field.

The life sciences field has seen a remarkable expansion in medical and drug development technologies thanks to advances in research and medical equipment. In the cancer field, one of the leading areas for drug development research, the use of 3D cell culturing has been accelerating, due to its ability to closely approximate an actual physical environment.

In 2011, the market was valued at $60 million and by 2016 it is expected to grow rapidly by around 4.5 times to reach approximately $274 million. However, the testing methods currently used in 3D cell culturing for cancer research mostly follow the conventional approach and involve first growing the cells and then adding pigments or other reagents and observing any changes.

As a result, there are several issues associated with this style of testing, including its labor-intensive nature and the inability to perform follow-up observations on the same cells. This has created a strong requirement for a testing system that can practically and comprehensively resolve these points.

To address this situation, Dainippon Screen developed the Cell3iMager. This 3D cell culture scanner permits the assessment of cell multiplication and morphological and follow-up observation without using reagents. Thanks to the application of Screen’s proprietary image processing technology, the system enables rapid measurement and analysis of multiplication and morphological changes in cancer cells grown on 3D culture plates over time.

In addition, as no reagent is applied, the same cancer cells can be used to continuously monitor the effects of experimental drugs without destroying the cells. In contrast to conventional testing systems, the Cell3iMager allows simple yet accurate observation of cancer cells and strongly supports drug development research using 3D cell culturing.

In conjunction with the development of the Cell3iMager, Screen enlisted the cooperation of Dr. Geoffrey Bartholomeusz and Professor Tamio Mizukami for a two year period to verify the utility of the system. Dr. Bartholomeusz is conducting research on the development of cancer drugs using 3D cell culturing at the University of Texas MD Anderson Cancer Center (MDACC), one of the world's leading facilities in the field of advanced cancer research. Professor Mizukami is based at the Nagahama Institute of Bio-Science and Technology, which specializes in the development of anticancer drugs.

The MDACC recently confirmed the Cell3iMager satisfied its required specifications, allowing the center to reach a final decision to officially adopt the device. Capitalizing on this opportunity, Screen has launched the Cell3iMager as a first step into the life sciences field. Screen intends to find new applications for its proprietary image processing technology in line with its plan to develop equipment that will contribute to the further expansion of this field.

By Chris Lui Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Dainippon Screen Mfg Co Ltd. News  
  Dainippon Screen to Release Transparent Electrodes Monitor for Touch Panels  (Apr 22, 2014)
  Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner  (Aug 8, 2013)
  Dainippon Screen Develops Wide-Format UV Inkjet Printing System  (June 25, 2013)
  Dainippon Screen to Market High-end Visual Inspection System for PCBs  (May 28, 2013)
  Hitachi High-Tech Opens Metrology and Inspection Center inside Dainippon Screen  (Dec 7, 2012)
  Dainippon Screen Introduces Wafer Cleaning System for Green Devices  (June 24, 2010)
  Dainippon Screen, Gifu University Devlop New Technology for Thin Film Solar Cells  (June 23, 2010)
  Dainippon Screen, DuPont to Develop OLED Display-Making Gear  (May 8, 2008)
  Dainippon Screen Mfg. Subsidiary Builds Wafer Cleaner Plant  (Jan 13, 2006)
  Dai Nippon Printing to Produce Plasma TV Panel Surface Film  (Dec 22, 2005)



 Recent  Medical News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)